-
Insightec wins new FDA approval for Parkinson's treatment
10 Jul 2025 21:18 GMT
"In two to three years, Insightec could be profitable," Dr. Maurice Ferré, CEO of the veteran Israel medical device company, told "Globes" recently. Insightec profitable? Let’s take a look. This is a company that in the course of its …
-
Scientists develop real-time imaging for brain drug uptake in Australia
11 Jul 2025 10:20 GMT
SYDNEY, July 11 (Xinhua) -- Scientists in Australia have developed an innovative device that integrates ultrasound and advanced imaging to enhance the safe delivery of drugs into the brain.
The technology could transform treatments of neurodegenerative …
-
Weekly injectable drug offers hope for Parkinson's patients
11 Jul 2025 05:23 GMT
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets.
Scientists from the University of South Australia (UniSA) have …
-
Study finds potential treatment path for Parkinson's linked to genetic mutation
11 Jul 2025 01:15 GMT
Stanford Medicine has led a study in mice that suggests inhibiting the LRRK2 enzyme could prevent neuron death in patients with a form of Parkinson’s disease caused by a genetic mutation. The research, published in Science Signaling, indicates that …
-
FDA releases ‘initial batch’ of more than 200 drug rejection letters
11 Jul 2025 00:15 GMT
The FDA has released an “initial batch“ of more than 200 complete response letters (CRLs) in efforts to boost transparency.
The attempt may have created more questions, however, with only certain letters shared and some documentation provided happening …
-
Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
10 Jul 2025 17:00 GMT
New York, USA, July 10, 2025 (GLOBE NEWSWIRE) -- Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The cannabinoid agonist market is gaining momentum due to …
-
London research: European cough medicine may aid Parkinson's patients
09 Jul 2025 22:20 GMT
Breadcrumb Trail Links
News
Local News
Can a drug used for decades in Europe to treat the common cough be repurposed to slow or stop the progression of certain kinds of dementia?
St. Joseph’s Health Care on Grosvenor Street in London. Photo taken on Monday …
-
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
09 Jul 2025 17:57 GMT
The Food and Drug Administration (FDA) has granted an expanded approval for Exablate Neuro, which utilizes MRI-guided ultrasound treatment, in staged bilateral pallidothalamic tractotomy procedures for patients with advanced Parkinson’s disease.
Insightec, …
-
Touro University in Nevada seeks volunteers for injectable weight-loss drugs study
09 Jul 2025 19:13 GMT
LAS VEGAS (KSNV) — Touro University Nevada is asking for volunteers to take part in a study on the long-term effects of injectable weight-loss or diabetic medication, such as Ozempic.
The university's College of Osteopathic Medicine will join the …
-
Korean researchers develop AI to diagnose Parkinson's disease with 99% accuracy
09 Jul 2025 08:23 GMT
Korean medical researchers have developed a generative AI technology capable of diagnosing Parkinson's disease -- which is often difficult to identify --with an accuracy of up to 99.7 percent and predicting changes in patients’ brain images.
Parkinson…